Battle Biotech · Research

Entry references

References

The 245 sources cited throughout the entry, in citation order. Superscript numbers in the paper correspond to the entries below. Each reference links to a PubMed and Google Scholar lookup.

Showing all 245 references

  1. Allnutt MA, Johnson K, Bennett DA, et al. Human Herpesvirus-6 (HHV-6) Detection in Alzheimer's Disease Cases and Controls Across Multiple Cohorts. SSRN Journal 2019.PubMed ↗Scholar ↗
  2. Jeong H-H, Liu Z. Are HHV-6A and HHV-7 Really More Abundant in Alzheimer's Disease? Neuron 2019;104:1034–5.PubMed ↗Scholar ↗
  3. Rizzo R. Controversial role of herpesviruses in Alzheimer's disease. PLoS Pathog 2020;16:e1008575.PubMed ↗Scholar ↗
  4. Ribalta T, Martinez AJ, Jares P, et al. Presence of occult cytomegalovirus infection in the brain after orthotopic liver transplantation. An autopsy study of 83 cases. Virchows Arch 2002;440:166–71.PubMed ↗Scholar ↗
  5. Cheeran MC-J, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection, Disease mechanisms and prospects for intervention. Clin Microbiol Rev 2009;22:99-126, Table of Contents.PubMed ↗Scholar ↗
  6. Razonable R. Cytomegalovirus infection in the brain of liver transplant recipients, Do pathologically occult infections matter clinically? Liver Transplantation 2003;9:313–5.PubMed ↗Scholar ↗
  7. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239–59.PubMed ↗Scholar ↗
  8. Tsartsalis S, Xekardaki A, Hof PR, Kövari E, Bouras C. Early Alzheimer-type lesions in cognitively normal subjects. Neurobiol Aging 2018;62:34–44.PubMed ↗Scholar ↗
  9. Braak H, Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 2011;121:171–81.PubMed ↗Scholar ↗
  10. Andrés-Benito et. al. Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology 2017.PubMed ↗Scholar ↗
  11. Deatly AM, Haase AT, Fewster PH, Lewis E, Ball MJ. Human herpes virus infections and Alzheimer's disease. Neuropathol Appl Neurobiol 1990;16:213–23.PubMed ↗Scholar ↗
  12. André Parent. Carpenter's Human Neuroanatomy. Baltimore: Williams and Wilkins, 1996. ISBN: 0-683-06752-4.PubMed ↗Scholar ↗
  13. Geerling JC, Shin J-W, Chimenti PC, Loewy AD. Paraventricular hypothalamic nucleus: axonal projections to the brainstem. THE JOURNAL OF COMPARATIVE NEUROLOGY 2010;518:1460–99.PubMed ↗Scholar ↗
  14. German DeaC. The Human Locus Coeruleus: Computer Reconstrution of Cellular Distribution. The Journal of Neuroscience 1988;8:1776–88.PubMed ↗Scholar ↗
  15. Young RF, Perryman KM. Pathways for orofacial pain sensation in the trigeminal brain-stem nuclear complex of the Macaque monkey. J Neurosurg 1984;61:563–8.PubMed ↗Scholar ↗
  16. Barnett EM, Cassell MD, Perlman S. Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 1993;57:1007–25.PubMed ↗Scholar ↗
  17. McLean Jea. Selective Lesions of Neural Pathways Following Viral Inoculation of the Olfactory Bulb. Exp Neurol 1993;122:209–22.PubMed ↗Scholar ↗
  18. Margolis TP, LaVail JH, Setzer PY, Dawson CR. Selective spread of herpes simplex virus in the central nervous system after ocular inoculation. J Virol 1989;63:4756–61.PubMed ↗Scholar ↗
  19. Steiner I, Mador N, Reibstein I, Spivack JG, Fraser NW. Herpes simplex virus type 1 gene expression and reactivation of latent infection in the central nervous system. Neuropathol Appl Neurobiol 1994;20:253–60.PubMed ↗Scholar ↗
  20. Olsson J, Lovheim H, Honkala E, Karhunen PJ, Elgh F, Kok EH. HSV presence in brains of individuals without dementia: the TASTY brain series. Dis Model Mech 2016;9:1349–55.PubMed ↗Scholar ↗
  21. Hu B, Li X, Huo Y, et al. Cellular responses to HSV-1 infection are linked to specific types of alterations in the host transcriptome. Sci Rep 2016;6:28075.PubMed ↗Scholar ↗
  22. Fraser NW, Lawrence WC, Wroblewska Z, Gilden DH, Koprowski H. Herpes simplex type 1 DNA in human brain tissue. Proceedings of the National Academy of Sciences 1981;78:6461–5.PubMed ↗Scholar ↗
  23. Baringer JR, Pisani P. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 1994;36:823–9.PubMed ↗Scholar ↗
  24. Theil D, Horn AKE, Derfuss T, Strupp M, Arbusow V, Brandt T. Prevalence and distribution of HSV-1, VZV, and HHV-6 in human cranial nerve nuclei III, IV, VI, VII, and XII. J Med Virol 2004;74:102–6.PubMed ↗Scholar ↗
  25. Nicoll MP, Hann W, Shivkumar M, et al. The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons. PLoS Pathog 2016;12:e1005539.PubMed ↗Scholar ↗
  26. Phelan EA, Borson S, Grothaus L, Balch S, Larson EB. Association of incident dementia with hospitalizations. JAMA 2012;307:165–72.PubMed ↗Scholar ↗
  27. Ehlenbach WJ, Hough CL, Crane PK, et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA 2010;303:763–70.PubMed ↗Scholar ↗
  28. Norton MC, Smith KR, Ostbye T, et al. Greater risk of dementia when spouse has dementia? The Cache County study, 2010. 11 p. (; vol. 58).PubMed ↗Scholar ↗
  29. Parry HM, Zuo J, Frumento G, et al. Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immun Ageing 2016;13:1.PubMed ↗Scholar ↗
  30. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 2007;42:563–70.PubMed ↗Scholar ↗
  31. Lupey-Green LN, Caruso LB, Madzo J, et al. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type. J Virol 2018;92.PubMed ↗Scholar ↗
  32. Thomasini RL, Pereira DS, Pereira FSM, et al. Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women. Here: MMMM, 2017. 111 ; 11 cm. (; vol. 12). ISBN: 1111111111.PubMed ↗Scholar ↗
  33. Stone DJ, Molony C, Suver C, Schadt EE, Potter WZ. ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease. Pharmacogenomics J 2010;10:161–4.PubMed ↗Scholar ↗
  34. Brogden G, Adamek M, Proepsting MJ, Ulrich R, Naim HY, Steinhagen D. Cholesterol-rich lipid rafts play an important role in the Cyprinid herpesvirus 3 replication cycle. Vet Microbiol 2015;179:204–12.PubMed ↗Scholar ↗
  35. Burgos JS, Ramirez C, Sastre I, Valdivieso F. Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. J Virol 2006;80:5383–7.PubMed ↗Scholar ↗
  36. Wudiri GA, Nicola AV. Cellular Cholesterol Facilitates the Postentry Replication Cycle of Herpes Simplex Virus 1. J Virol 2017;91.PubMed ↗Scholar ↗
  37. Wudiri GA, Schneider SM, Nicola AV. Herpes Simplex Virus 1 Envelope Cholesterol Facilitates Membrane Fusion. Front Microbiol 2017;8:2383.PubMed ↗Scholar ↗
  38. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921–3.PubMed ↗Scholar ↗
  39. Corder E, Lannfelt L, Mulder M. Apolipoprotein E and herpes simplex virus 1 in Alzheimer's disease. The Lancet 1998;352:1312–3.PubMed ↗Scholar ↗
  40. Miller RM, Federoff HJ. Isoform-specific effects of ApoE on HSV immediate early gene expression and establishment of latency. Neurobiol Aging 2008;29:71–7.PubMed ↗Scholar ↗
  41. Itzhaki RF, Wozniak MA. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. Prog Lipid Res 2006;45:73–90.PubMed ↗Scholar ↗
  42. Igbavboa U, Eckert GP, Malo TM, et al. Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human apoE 3 and 4 and by increasing age. J Neurol Sci 2005;229-230:225–32.PubMed ↗Scholar ↗
  43. Schneider A, Rajendran L, Honsho M, et al. Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J Neurosci 2008;28:2874–82.PubMed ↗Scholar ↗
  44. Lang J, Bohn P, Bhat H, et al. Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease. Nat Commun 2020;11:1338.PubMed ↗Scholar ↗
  45. Bentz GL, Jarquin-Pardo M, Chan G, Smith MS, Sinzger C, Yurochko AD. Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J Virol 2006;80:11539–55.PubMed ↗Scholar ↗
  46. Caruso A, Rotola A, Comar M, et al. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol 2002;67:528–33.PubMed ↗Scholar ↗
  47. Casiraghi C, Dorovini-Zis K, Horwitz MS. Epstein-Barr virus infection of human brain microvessel endothelial cells, A novel role in multiple sclerosis. J Neuroimmunol 2011;230:173–7.PubMed ↗Scholar ↗
  48. Jones K, Rivera C, Sgadari C, et al. Infection of human endothelial cells with Epstein-Barr virus. J Exp Med 1995;182:1213–21.PubMed ↗Scholar ↗
  49. Key NS, Vercellotti GM, Winkelmann JC, et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proceedings of the National Academy of Sciences 1990;87:7095–9.PubMed ↗Scholar ↗
  50. Scheglovitova ON, Romanov YA, Maksianina EV, Svintsitskaya VA, Pronin AG. Herpes simplex type I virus infected human vascular endothelial cells induce the production of anti-viral and proinflammatory factors by peripheral blood leukocytes in vitro. Russ J Immunol 2002;7:115–22.PubMed ↗Scholar ↗
  51. Sonzogni O, Millard A-L, Taveira A, et al. Efficient Human Cytomegalovirus Replication in Primary Endothelial Cells Is SOCS3 Dependent. Intervirology 2019;62:80–9.PubMed ↗Scholar ↗
  52. Takatsuka H, Wakae T, Mori A, et al. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant 2003;31:475–9.PubMed ↗Scholar ↗
  53. Wu CA, Shanley JD. Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J Gen Virol 1998;79 ( Pt 5):1247–56.PubMed ↗Scholar ↗
  54. Alcendor DJ. Human Vascular Pericytes and Cytomegalovirus Pathobiology. Int J Mol Sci 2019;20.PubMed ↗Scholar ↗
  55. Menet A, Speth C, Larcher C, et al. Epstein-Barr virus infection of human astrocyte cell lines. J Virol 1999;73:7722–33.PubMed ↗Scholar ↗
  56. Lokensgard JR, Cheeran MC, Gekker G, Hu S, Chao CC, Peterson PK. Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J Hum Virol 1999;2:91– 101.PubMed ↗Scholar ↗
  57. Vanheusden M, Broux B, Welten SPM, et al. Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation. Sci Rep 2017;7:134.PubMed ↗Scholar ↗
  58. Abdel-Hamid M, Chen J-J, Constantine N, Massoud M, Raab-Traub N. EBV strain variation, Geographical distribution and relation to disease state. Virology 1992;190:168– 75.PubMed ↗Scholar ↗
  59. Salgado H, Treviño M, Atzori M. Layer- and area-specific actions of norepinephrine on cortical synaptic transmission. Brain Res 2016;1641:163–76.PubMed ↗Scholar ↗
  60. Granstedt AE, Bosse JB, Thiberge SY, Enquist LW. In vivo imaging of alphaherpesvirus infection reveals synchronized activity dependent on axonal sorting of viral proteins. Proc Natl Acad Sci U S A 2013;110:E3516-25.PubMed ↗Scholar ↗
  61. Elrod R, Peskind ER, DiGiacomo L, Brodkin KI, Veith RC, Raskind MA. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiatry 1997;154:25–30.PubMed ↗Scholar ↗
  62. Edgar RS, Stangherlin A, Nagy AD, et al. Cell autonomous regulation of herpes and influenza virus infection by the circadian clock. Proc Natl Acad Sci U S A 2016;113:10085– 90.PubMed ↗Scholar ↗
  63. Brzecka A, Leszek J, Ashraf GM, et al. Sleep Disorders Associated With Alzheimer's Disease, A Perspective. Front Neurosci 2018;12:330.PubMed ↗Scholar ↗
  64. Chiara G de, Marcocci ME, Civitelli L, et al. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 2010;5:e13989.PubMed ↗Scholar ↗
  65. Shipley SJ, Parkin ET, Itzhaki RF, Dobson CB. Herpes simplex virus interferes with amyloid precursor protein processing. BMC Microbiol 2005;5:48.PubMed ↗Scholar ↗
  66. Chai Q, Jovasevic V, Malikov V, et al. HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration. Nat Commun 2017;8:1522.PubMed ↗Scholar ↗
  67. Hategan A, Masliah E, Nath A. HIV and Alzheimer's disease, Complex interactions of HIV-Tat with amyloid β peptide and Tau protein. J Neurovirol 2019;25:648–60.PubMed ↗Scholar ↗
  68. Cribbs DH, Azizeh BY, Cotman CW, LaFerla FM. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. Biochemistry 2000;39:5988–94.PubMed ↗Scholar ↗
  69. Niazy N, Temme S, Bocuk D, et al. Misdirection of endosomal trafficking mediated by herpes simplex virus-encoded glycoprotein B. FASEB J 2017;31:1650–67.PubMed ↗Scholar ↗
  70. Cataldo AM, Petanceska S, Terio NB, et al. Abeta localization in abnormal endosomes, Association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging 2004;25:1263–72.PubMed ↗Scholar ↗
  71. Xu W, Fang F, Ding J, Wu C. Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease. Traffic 2018;19:253–62.PubMed ↗Scholar ↗
  72. Temme S, Eis-Hübinger AM, McLellan AD, Koch N. The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J Immunol 2010;184:236– 43.PubMed ↗Scholar ↗
  73. Laifenfeld D, Patzek LJ, McPhie DL, et al. Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis. J Neurosci 2007;27:7141–53.PubMed ↗Scholar ↗
  74. Sil S, Hu G, Liao K, et al. HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis. PLoS Biol 2020;18:e3000660.PubMed ↗Scholar ↗
  75. van Broeckhoven C, Kumar-Singh S. Genetics and pathology of alpha-secretase site AbetaPP mutations in the understanding of Alzheimer's disease. J Alzheimers Dis 2006;9:389–98.PubMed ↗Scholar ↗
  76. O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 2011;34:185–204.PubMed ↗Scholar ↗
  77. Lauritzen I, Pardossi-Piquard R, Bourgeois A, et al. Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology. Acta Neuropathol 2016;132:257–76.PubMed ↗Scholar ↗
  78. García-Ayllón M-S, Lopez-Font I, Boix CP, et al. C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease. Sci Rep 2017;7:2477.PubMed ↗Scholar ↗
  79. Vaillant-Beuchot L, Mary A, Pardossi-Piquard R, et al. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains. Acta Neuropathol 2020.PubMed ↗Scholar ↗
  80. Soh TK, Davies CTR, Muenzner J, et al. Temporal Proteomic Analysis of Herpes Simplex Virus 1 Infection Reveals Cell-Surface Remodeling via pUL56-Mediated GOPC Degradation. Cell Rep 2020;33:108235.PubMed ↗Scholar ↗
  81. Bellner L, Thorén F, Nygren E, Liljeqvist J-A, Karlsson A, Eriksson K. A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions. J Immunol 2005;174:2235–41.PubMed ↗Scholar ↗
  82. Sciortino MT, Taddeo B, Poon APW, Mastino A, Roizman B. Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection. Proceedings of the National Academy of Sciences 2002;99:8318–23.PubMed ↗Scholar ↗
  83. Pachl C, Burke RL, Stuve LL, et al. Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells. J Virol 1987;61:315– 25.PubMed ↗Scholar ↗
  84. Wildemann B, Ehrhart K, Storch-Hagenlocher B, et al. Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology 1997;48:1341–6.PubMed ↗Scholar ↗
  85. Tandon R, Mocarski ES. Viral and host control of cytomegalovirus maturation. Trends Microbiol 2012;20:392–401.PubMed ↗Scholar ↗
  86. Indran SV, Ballestas ME, Britt WJ. Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells. J Virol 2010;84:3162–77.PubMed ↗Scholar ↗
  87. Indran SV, Britt WJ. A Role for the Small GTPase Rab6 in Assembly of Human Cytomegalovirus. J Virol 2011;85:5213–9.PubMed ↗Scholar ↗
  88. Thyrock A, Ossendorf E, Stehling M, et al. A new Mint1 isoform, but not the conventional Mint1, interacts with the small GTPase Rab6. PLoS One 2013;8:e64149.PubMed ↗Scholar ↗
  89. Scheper W, Hoozemans JJM, Hoogenraad CC, Rozemuller AJM, Eikelenboom P, Baas F. Rab6 is increased in Alzheimer's disease brain and correlates with endoplasmic reticulum stress. Neuropathol Appl Neurobiol 2007;0:070615152525001-???PubMed ↗Scholar ↗
  90. Schlager MA, Kapitein LC, Grigoriev I, et al. Pericentrosomal targeting of Rab6 secretory vesicles by Bicaudal-D-related protein 1 (BICDR-1) regulates neuritogenesis. EMBO J 2010;29:1637–51.PubMed ↗Scholar ↗
  91. Patwardhan A, Bardin S, Miserey-Lenkei S, et al. Routing of the RAB6 secretory pathway towards the lysosome related organelle of melanocytes. Nat Commun 2017;8:15835.PubMed ↗Scholar ↗
  92. Dumortier J, Streblow DN, Moses AV, et al. Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing. JVI 2008;82:6524–35.PubMed ↗Scholar ↗
  93. Luganini A, Terlizzi ME, Gribaudo G. Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus. Front Microbiol 2016;7:715.PubMed ↗Scholar ↗
  94. Mocarski ES, Pereira L, McCormick AL. Human cytomegalovirus ICP22, the product of the HWLF1 reading frame, is an early nuclear protein that is released from cells. J Gen Virol 1988;69 ( Pt 10):2613–21.PubMed ↗Scholar ↗
  95. Renvoize EB, Hambling MH, Pepper MD, Rajah SM. Possible association of Alzheimer's disease with HLA-BW15 and cytomegalovirus infection. The Lancet 1979;1:1238.PubMed ↗Scholar ↗
  96. Bakker PIW de, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006;38:1166–72.PubMed ↗Scholar ↗
  97. Steele NZR, Carr JS, Bonham LW, et al. Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease, A case-control study. PLoS Med 2017;14:e1002272.PubMed ↗Scholar ↗
  98. Barnes LL, Capuano AW, Aiello AE, et al. Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis 2015;211:230–7.PubMed ↗Scholar ↗
  99. Lurain NS, Hanson BA, Martinson J, et al. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis 2013;208:564–72.PubMed ↗Scholar ↗
  100. Dickerson F, Stallings C, Origoni A, et al. Association between cytomegalovirus antibody levels and cognitive functioning in non-elderly adults. PLoS One 2014;9:e95510.PubMed ↗Scholar ↗
  101. Westman G, Berglund D, Widén J, et al. Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer's disease. PLoS One 2014;9:e96779.PubMed ↗Scholar ↗
  102. Lurain NS, Hanson BA, Martinson J, et al. Virological and Immunological Characteristics of Human Cytomegalovirus Infection Associated With Alzheimer Disease. J Infect Dis 2013;208:564–72.PubMed ↗Scholar ↗
  103. AuCoin DP, Smith GB, Meiering CD, Mocarski ES. Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol 2006;80:8199–210.PubMed ↗Scholar ↗
  104. Rotola A, Ravaioli T, Gonelli A, Dewhurst S, Cassai E, Di Luca D. U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proceedings of the National Academy of Sciences 1998;95:13911–6.PubMed ↗Scholar ↗
  105. Rizzo R, D'Accolti M, Bortolotti D, et al. Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G. Sci Rep 2018;8:17683.PubMed ↗Scholar ↗
  106. Aung HH, Altman R, Nyunt T, et al. Lipotoxic brain microvascular injury is mediated by activating transcription factor 3-dependent inflammatory and oxidative stress pathways. J Lipid Res 2016;57:955–68.PubMed ↗Scholar ↗
  107. Fons P, Chabot S, Cartwright JE, et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006;108:2608–15.PubMed ↗Scholar ↗
  108. Le Bouteiller P, Fons P, Herault J-P, et al. Soluble HLA-G and control of angiogenesis. J Reprod Immunol 2007;76:17–22.PubMed ↗Scholar ↗
  109. Wiendl H, Feger U, Mittelbronn M, et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis, Implications for CNS immunity. Brain 2005;128:2689–704.PubMed ↗Scholar ↗
  110. Steel AJ, Eslick GD. Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis. J Alzheimers Dis 2015;47:351–64.PubMed ↗Scholar ↗
  111. Westman G, Blomberg J, Yun Z, Lannfelt L, Ingelsson M, Eriksson B-M. Decreased HHV-6 IgG in Alzheimer's Disease. Front Neurol 2017;8:40.PubMed ↗Scholar ↗
  112. Readhead B, Haure-Mirande J-V, Funk CC, et al. Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron 2018;99:64-82.e7.PubMed ↗Scholar ↗
  113. Timens W, Boes A, Vos H, Poppema S. Tissue distribution of the C3d/EBV- receptor, CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells. Histochemistry 1991;95:605–11.PubMed ↗Scholar ↗
  114. Collard CD, Bukusoglu C, Agah A, et al. Hypoxia-induced expression of complement receptor type 1 (CR1, CD35) in human vascular endothelial cells. Am J Physiol 1999;276:C450-8.PubMed ↗Scholar ↗
  115. Kosenko EA, Tikhonova LA, Montoliu C, Barreto GE, Aliev G, Kaminsky YG. Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease. Front Neurosci 2017;11:728.PubMed ↗Scholar ↗
  116. Lin S-Y, Hsu W-H, Lin C-C, Lin C-L, Yeh H-C, Kao C-H. Association of Transfusion With Risks of Dementia or Alzheimer's Disease, A Population-Based Cohort Study. Front Psychiatry 2019;10:571.PubMed ↗Scholar ↗
  117. Jha HC, Mehta D, Lu J, et al. Gammaherpesvirus Infection of Human Neuronal Cells. MBio 2015;6:e01844-15.PubMed ↗Scholar ↗
  118. van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MMB. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 2005;36:2637–41.PubMed ↗Scholar ↗
  119. Cortes-Canteli M, Kruyer A, Fernandez-Nueda I, et al. Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model. J Am Coll Cardiol 2019;74:1910–23.PubMed ↗Scholar ↗
  120. Tang L-Q, Chen Q-Y, Guo S-S, et al. The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis, An observational study. Br J Cancer 2014;111:1102–11.PubMed ↗Scholar ↗
  121. Mari D, Parnetti L, Coppola R, et al. Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease. Thromb Haemost 1996;75:216–8.PubMed ↗Scholar ↗
  122. Cuccaro ML, Carney RM, Zhang Y, et al. SORL1 mutations in early- and late- onset Alzheimer disease. Neurol Genet 2016;2:e116.PubMed ↗Scholar ↗
  123. Darr CD, Mauser A, Kenney S. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol 2001;75:6135–42.PubMed ↗Scholar ↗
  124. Robinson AR, Kwek SS, Hagemeier SR, Wille CK, Kenney SC. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency. J Virol 2011;85:8940–53.PubMed ↗Scholar ↗
  125. Holzerlandt R, Orengo C, Kellam P, Albà MM. Identification of New Herpesvirus Gene Homologs in the Human Genome. Genome Res 2002;12:1739–48.PubMed ↗Scholar ↗
  126. Ciarlo E, Massone S, Penna I, et al. An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples. Dis Model Mech 2013;6:424–33.PubMed ↗Scholar ↗
  127. Yang Y, Mufson EJ, Herrup K. Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease. J. Neurosci. 2003;23:2557–63.PubMed ↗Scholar ↗
  128. Frade JM, López-Sánchez N. Neuronal tetraploidy in Alzheimer and aging. Aging 2017;9:2014–5.PubMed ↗Scholar ↗
  129. Herrup K. The involvement of cell cycle events in the pathogenesis of Alzheimer's disease. Alzheimers Res Ther 2010;2:13.PubMed ↗Scholar ↗
  130. Barrio-Alonso E, Hernández-Vivanco A, Walton CC, Perea G, Frade JM. Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons. Sci Rep 2018;8:14316.PubMed ↗Scholar ↗
  131. Yin H, Qu J, Peng Q, Gan R. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol 2019;208:573–83.PubMed ↗Scholar ↗
  132. Yajima M, Kanda T, Takada K. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J Virol 2005;79:4298–307.PubMed ↗Scholar ↗
  133. Greene LA, Liu DX, Troy CM, Biswas SC. Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim Biophys Acta 2007;1772:392– 401.PubMed ↗Scholar ↗
  134. Biswas SC, Shi Y, Vonsattel J-PG, Leung CL, Troy CM, Greene LA. Bim is elevated in Alzheimer's disease neurons and is required for beta-amyloid-induced neuronal apoptosis. J Neurosci 2007;27:893–900.PubMed ↗Scholar ↗
  135. Iwakiri D, Zhou L, Samanta M, et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 2009;206:2091–9.PubMed ↗Scholar ↗
  136. Toczyski DP, Matera AG, Ward DC, Steitz JA. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proceedings of the National Academy of Sciences 1994;91:3463–7.PubMed ↗Scholar ↗
  137. Cameron JS, Alexopoulou L, Sloane JA, et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 2007;27:13033–41.PubMed ↗Scholar ↗
  138. Vuyisich M, Spanggord RJ, Beal PA. The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus. EMBO Rep 2002;3:622–7.PubMed ↗Scholar ↗
  139. Cheng S, Li Z, He J, et al. Epstein-Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression. Biochim Biophys Acta Mol Basis Dis 2019;1865:1201–13.PubMed ↗Scholar ↗
  140. Desai BS, Schneider JA, Li J-L, Carvey PM, Hendey B. Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna) 2009;116:587–97.PubMed ↗Scholar ↗
  141. Lee Y-C, Lee L-Y, Tsang N-M, et al. Prognostic Significance of Granuloma and Amyloid Deposition in Nasopharyngeal Carcinoma. Head Neck Pathol 2020.PubMed ↗Scholar ↗
  142. Ikeda M, Longnecker R. Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology 2007;360:461–8.PubMed ↗Scholar ↗
  143. Verweij FJ, van Eijndhoven MAJ, Hopmans ES, et al. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation. EMBO J 2011;30:2115–29.PubMed ↗Scholar ↗
  144. Carbone I, Lazzarotto T, Ianni M, et al. Herpes virus in Alzheimer's disease, Relation to progression of the disease. Neurobiol Aging 2014;35:122–9.PubMed ↗Scholar ↗
  145. Panikkar A, Smith C, Hislop A, et al. Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus-Associated Acute Infectious Mononucleosis, Implication for Immune Dysregulation. J Infect Dis 2015;212:1957–61.PubMed ↗Scholar ↗
  146. Ciaramella A, Salani F, Bizzoni F, et al. Myeloid dendritic cells are decreased in peripheral blood of Alzheimer’s disease patients in association with disease progression and severity of depressive symptoms. J Neuroinflammation 2016;13:383.PubMed ↗Scholar ↗
  147. Gate D, Saligrama N, Leventhal O, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature 2020;577:399–404.PubMed ↗Scholar ↗
  148. Ounanian A, Guilbert B, Seigneurin J-M. Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls. Mech Ageing Dev 1992;63:105–16.PubMed ↗Scholar ↗
  149. Chung SJ, Kim M-J, Kim YJ, et al. CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease. J Neurol Sci 2014;339:91–6.PubMed ↗Scholar ↗
  150. Lu R-C, Yang W, Tan L, et al. Association of HLA-DRB1 polymorphism with Alzheimer's disease, A replication and meta-analysis. Oncotarget 2017;8:93219–26.PubMed ↗Scholar ↗
  151. Jabs WJ, Paulsen M, Wagner HJ, Kirchner H, Klüter H. Analysis of Epstein-Barr virus (EBV) receptor CD21 on peripheral B lymphocytes of long-term EBV- adults. Clinical & Experimental Immunology 1999;116:468–73.PubMed ↗Scholar ↗
  152. James LM, Christova P, Lewis SM, Engdahl BE, Georgopoulos A, Georgopoulos AP. Protective Effect of Human Leukocyte Antigen (HLA) Allele DRB1*13:02 on Age-Related Brain Gray Matter Volume Reduction in Healthy Women. EBioMedicine 2018;29:31–7.PubMed ↗Scholar ↗
  153. Harley JB, Chen X, Pujato M, et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet 2018;50:699–707.PubMed ↗Scholar ↗
  154. Parks CG, Cooper GS, Hudson LL, et al. Association of Epstein-Barr virus with systemic lupus erythematosus, Effect modification by race, age, and cytotoxic T lymphocyte- associated antigen 4 genotype. Arthritis Rheum 2005;52:1148–59.PubMed ↗Scholar ↗
  155. Croia C, Astorri E, Murray-Brown W, et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome. Arthritis & rheumatology (Hoboken, N.J.) 2014;66:2545–57.PubMed ↗Scholar ↗
  156. Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204:2899–912.PubMed ↗Scholar ↗
  157. Mechelli R, Manzari C, Policano C, et al. Epstein-Barr virus genetic variants are associated with multiple sclerosis. Neurology 2015;84:1362–8.PubMed ↗Scholar ↗
  158. Hou T-Y, Hsu H-C, Lin T-M, et al. Higher risk of dementia in primary Sjogren's syndrome. Ann Clin Transl Neurol 2019;6:633–41.PubMed ↗Scholar ↗
  159. Luczynski P, Laule C, Hsiung G-YR, Moore GRW, Tremlett H. Coexistence of Multiple Sclerosis and Alzheimer's disease, A review. Mult Scler Relat Disord 2019;27:232–8.PubMed ↗Scholar ↗
  160. Chen H-H, Perng W-T, Chiou J-Y, Wang Y-H, Huang J-Y, Wei JC-C. Risk of dementia among patients with Sjogren's syndrome, A nationwide population-based cohort study in Taiwan. Semin Arthritis Rheum 2019;48:895–9.PubMed ↗Scholar ↗
  161. Zhao Z, Rocha NP, Salem H, Diniz BS, Teixeira AL. The association between systemic lupus erythematosus and dementia A meta-analysis. Dement Neuropsychol 2018;12:143–51.PubMed ↗Scholar ↗
  162. Chen Y, Peng Y, Che P, et al. α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction. Proc Natl Acad Sci U S A 2014;111:17296–301.PubMed ↗Scholar ↗
  163. Zhang F, Gannon M, Chen Y, Zhou L, Jiao K, Wang Q. The amyloid precursor protein modulates α2A-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment. FASEB J 2017;31:4434–46.PubMed ↗Scholar ↗
  164. Washburn M, Moises HC. Electrophysiological correlates of presynaptic alpha 2- receptor- mediated inhibition of norepinephrine release at locus coeruleus synapses in dentate gyrus. J. Neurosci. 1989;9:2131–40.PubMed ↗Scholar ↗
  165. Kalaria RN, Andorn AC. Adrenergic receptors in aging and Alzheimer's disease, Decreased α2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortex. Neurobiol Aging 1991;12:131–6.PubMed ↗Scholar ↗
  166. Szili-Török T, Kálmán J, Paprika D, Dibó G, Rózsa Z, Rudas L. Depressed baroreflex sensitivity in patients with Alzheimer’s and Parkinson’s disease. Neurobiol Aging 2001;22:435–8.PubMed ↗Scholar ↗
  167. Niederhoffer N, Hein L, Starke K. Modulation of the baroreceptor reflex by alpha 2A-adrenoceptors, A study in alpha 2A knockout mice. Br J Pharmacol 2004;141:851–9.PubMed ↗Scholar ↗
  168. Ni Y, Zhao X, Bao G, et al. Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat Med 2006;12:1390–6.PubMed ↗Scholar ↗
  169. Lee RK, Araki W, Wurtman RJ. Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation. Proceedings of the National Academy of Sciences 1997;94:5422–6.PubMed ↗Scholar ↗
  170. Kurt MA, Davies DC, Kidd M. beta-Amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies, An electron microscope study. Exp Neurol 1999;158:221–8.PubMed ↗Scholar ↗
  171. Gaidin SG, Zinchenko VP, Sergeev AI, Teplov IY, Mal'tseva VN, Kosenkov AM. Activation of alpha-2 adrenergic receptors stimulates GABA release by astrocytes. Glia 2020;68:1114–30.PubMed ↗Scholar ↗
  172. Umeda T, Kimura T, Yoshida K, et al. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease, Analysis of Osaka mutation-knockin mice. Acta Neuropathol Commun 2017;5:59.PubMed ↗Scholar ↗
  173. Ge S, Pradhan DA, Ming G-L, Song H. GABA sets the tempo for activity- dependent adult neurogenesis. Trends Neurosci 2007;30:1–8.PubMed ↗Scholar ↗
  174. Ge S, Goh ELK, Sailor KA, Kitabatake Y, Ming G-L, Song H. GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature 2006;439:589–93.PubMed ↗Scholar ↗
  175. Moreno-Jiménez EP, Flor-García M, Terreros-Roncal J, et al. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease. Nat Med 2019;25:554–60.PubMed ↗Scholar ↗
  176. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009;62:788–801.PubMed ↗Scholar ↗
  177. Sheng M, Ertürk A. Long-term depression, A cell biological view. Philos Trans R Soc Lond , B, Biol Sci 2014;369:20130138.PubMed ↗Scholar ↗
  178. Sernagor E, Chabrol F, Bony G, Cancedda L. GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis, General rules and differences in diverse systems. Front Cell Neurosci 2010;4:11.PubMed ↗Scholar ↗
  179. Liu W, Yuen EY, Allen PB, Feng J, Greengard P, Yan Z. Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin. Proceedings of the National Academy of Sciences 2006;103:18338–43.PubMed ↗Scholar ↗
  180. Aoki C. Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cerebral Cortex 1998;8:269–77.PubMed ↗Scholar ↗
  181. Zhang F, Gannon M, Chen Y, et al. β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade. Sci Transl Med 2020;12.PubMed ↗Scholar ↗
  182. Hadar A, Milanesi E, Squassina A, et al. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining. Transl Psychiatry 2016;6:e909.PubMed ↗Scholar ↗
  183. Levy BH, Tasker JG. Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress. Front Cell Neurosci 2012;6:24.PubMed ↗Scholar ↗
  184. Qiao G, Chen M, Bucsek MJ, Repasky EA, Hylander BL. Adrenergic Signaling, A Targetable Checkpoint Limiting Development of the Antitumor Immune Response. Front Immunol 2018;9:164.PubMed ↗Scholar ↗
  185. Bettcher BM, Johnson SC, Fitch R, et al. Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage. J Alzheimers Dis 2018;62:385–97.PubMed ↗Scholar ↗
  186. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proceedings of the National Academy of Sciences 2000;97:1695–700.PubMed ↗Scholar ↗
  187. Poole E, Sinclair J. Sleepless latency of human cytomegalovirus. Med Microbiol Immunol 2015;204:421–9.PubMed ↗Scholar ↗
  188. Young V. Detection of HCMV viral IL-10 (vIL-10) in healthy blood donors [Master's Thesis]. San Francisco: University of San Francisco, 2015. 58 p. Available from: https://repository.usfca.edu/cgi/viewcontent.cgi?article=1182&context=thes.PubMed ↗Scholar ↗
  189. Kitagawa N, Goto M, Kurozumi K, et al. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J 2000;19:6742–50.PubMed ↗Scholar ↗
  190. Wang D, Bresnahan W, Shenk T. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proceedings of the National Academy of Sciences 2004;101:16642–7.PubMed ↗Scholar ↗
  191. Milne RS, Mattick C, Nicholson L, Devaraj P, Alcami A, Gompels UA. RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J Immunol 2000;164:2396–404.PubMed ↗Scholar ↗
  192. Abate DA, Watanabe S, Mocarski ES. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 2004;78:10995–1006.PubMed ↗Scholar ↗
  193. Irmiere A, Gibson W. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 1983;130:118–33.PubMed ↗Scholar ↗
  194. Apoil PA, Puissant-Lubrano B, Congy-Jolivet N, et al. Influence of age, sex and HCMV-serostatus on blood lymphocyte subpopulations in healthy adults. Cell Immunol 2017;314:42–53.PubMed ↗Scholar ↗
  195. Callender LA, Carroll EC, Beal RWJ, et al. Human CD8+ EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK. Aging Cell 2018;17.PubMed ↗Scholar ↗
  196. Pisa D, Alonso R, Fernández-Fernández AM, Rábano A, Carrasco L. Polymicrobial Infections In Brain Tissue From Alzheimer's Disease Patients. Sci Rep 2017;7:5559.PubMed ↗Scholar ↗
  197. Alonso R, Pisa D, Fernández-Fernández AM, Carrasco L. Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer's Disease. Front Aging Neurosci 2018;10:159.PubMed ↗Scholar ↗
  198. Balin BJ, Gérard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 1998;187:23–42.PubMed ↗Scholar ↗
  199. Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer's disease brains, Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 2019;5:eaau3333.PubMed ↗Scholar ↗
  200. Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol 2002;17:113–8.PubMed ↗Scholar ↗
  201. Lin C-H, Chien W-C, Chung C-H, et al. Increased risk of dementia in patients with genital warts, A nationwide cohort study in Taiwan. J Dermatol 2020;47:503–11.PubMed ↗Scholar ↗
  202. Sasaki N, Fukatsu R, Tsuzuki K, et al. Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases. The American Journal of Pathology 1998;153:1149–55.PubMed ↗Scholar ↗
  203. Bedse G, Di Domenico F, Serviddio G, Cassano T. Aberrant insulin signaling in Alzheimer's disease: current knowledge. Front Neurosci 2015;9:PubMed ↗Scholar ↗
  204. 204. Bingham EM, Hopkins D, Smith D, et al. The role of insulin in human brain glucose metabolism, An 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002;51:3384–90.PubMed ↗Scholar ↗
  205. Grillo CA, Piroli GG, Hendry RM, Reagan LP. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res 2009;1296:35–45.PubMed ↗Scholar ↗
  206. McNay EC, Pearson-Leary J. GluT4, A central player in hippocampal memory and brain insulin resistance. Exp Neurol 2020;323:113076.PubMed ↗Scholar ↗
  207. Grillo CA, Piroli GG, Lawrence RC, et al. Hippocampal Insulin Resistance Impairs Spatial Learning and Synaptic Plasticity. Diabetes 2015;64:3927–36.PubMed ↗Scholar ↗
  208. Rizza RA, Cryer PE, Haymond MW, Gerich JE. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man. Metabolism 1980;29:1155–63.PubMed ↗Scholar ↗
  209. Belfort-DeAguiar R, Gallezot J-D, Hwang JJ, et al. Noradrenergic Activity in the Human Brain, A Mechanism Supporting the Defense Against Hypoglycemia. J Clin Endocrinol Metab 2018;103:2244–52.PubMed ↗Scholar ↗
  210. Straub SG, Sharp GWG. Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins. Am J Physiol , Cell Physiol 2012;302:C1687-98.PubMed ↗Scholar ↗
  211. Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab 2003;284:E7-12.PubMed ↗Scholar ↗
  212. Kong Y, Wang F, Wang J, et al. Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease, The Receptor for Advanced Glycation End Products (RAGE). Front Aging Neurosci 2020;12:217.PubMed ↗Scholar ↗
  213. Kierdorf K, Fritz G. RAGE regulation and signaling in inflammation and beyond. J Leukoc Biol 2013;94:55–68.PubMed ↗Scholar ↗
  214. Gasparotto J, Girardi CS, Somensi N, et al. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment. J Biol Chem 2018;293:226–44.PubMed ↗Scholar ↗
  215. Ahmed SAH, Ansari SA, Mensah-Brown EPK, Emerald BS. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus. Clin Epigenetics 2020;12:104.PubMed ↗Scholar ↗
  216. Farkas E, Jong GI de, Vos RA de, Jansen Steur EN, Luiten PG. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol 2000;100:395–402.PubMed ↗Scholar ↗
  217. Miyakawa T. Electron microscopy of amyloid fibrils and microvessels. Ann N Y Acad Sci 1997;826:25–34.PubMed ↗Scholar ↗
  218. Brenowitz WD, Nelson PT, Besser LM, Heller KB, Kukull WA. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes. Neurobiol Aging 2015;36:2702–8.PubMed ↗Scholar ↗
  219. Qin W, Jia X, Wang F, et al. Elevated plasma angiogenesis factors in Alzheimer's disease. J Alzheimers Dis 2015;45:245–52.PubMed ↗Scholar ↗
  220. Satou R, Penrose H, Navar LG. Inflammation as a Regulator of the Renin- Angiotensin System and Blood Pressure. Curr Hypertens Rep 2018;20:100.PubMed ↗Scholar ↗
  221. Sun Y, PEI W, WU Y, JING Z, ZHANG J, WANG G. Herpes Simplex Virus Type 2 Infection Is a Risk Factor for Hypertension. Hypertens Res 2004;27:541–4.PubMed ↗Scholar ↗
  222. Riedel K, Deussen AJ, Tolkmitt J, et al. Estrogen determines sex differences in adrenergic vessel tone by regulation of endothelial β-adrenoceptor expression. Am J Physiol Heart Circ Physiol 2019;317:H243-H254.PubMed ↗Scholar ↗
  223. Abramson BL, Srivaratharajah K, Davis LL, Parapid. Women and Hypertension: Beyond the 2017 Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol 2018.PubMed ↗Scholar ↗
  224. Hinojosa-Laborde C, Craig T, Zheng W, Ji H, Haywood JR, Sandberg K. Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 2004;44:405–9.PubMed ↗Scholar ↗
  225. Baird AL, Westwood S, Lovestone S. Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology. Front Neurol 2015;6:236.PubMed ↗Scholar ↗
  226. Huang C-W, Tsai M-H, Chen N-C, et al. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia. Thromb Haemost 2015;114:1230–40.PubMed ↗Scholar ↗
  227. Reijmer YD, van Veluw SJ, Greenberg SM. Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab 2016;36:40–54.PubMed ↗Scholar ↗
  228. Korte N, Nortley R, Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease. Acta Neuropathol 2020;11:149.PubMed ↗Scholar ↗
  229. Da Mesquita S, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature 2018;560:185–91.PubMed ↗Scholar ↗
  230. Bennett SAL, Pappas BA, Stevens WD, Davidson CM, Fortin T, Chen J. Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion. Neurobiol Aging 2000;21:207–14.PubMed ↗Scholar ↗
  231. Raz L, Bhaskar K, Weaver J, et al. Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction. Neurobiology of Disease 2019;126:124–36.PubMed ↗Scholar ↗
  232. Kirino T, Tamura A, Sano K. Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 1984;64:139–47.PubMed ↗Scholar ↗
  233. Frenkel-Denkberg G, Gershon D, Levy AP. The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice. FEBS Lett 1999;462:341–4.PubMed ↗Scholar ↗
  234. Zhang Y-w, Chen Y, Liu Y, Zhao Y, Liao F-F, Xu H. APP regulates NGF receptor trafficking and NGF-mediated neuronal differentiation and survival. PLoS One 2013;8:e80571.PubMed ↗Scholar ↗
  235. Wang B, Yang L, Wang Z, Zheng H. Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter. Proceedings of the National Academy of Sciences 2007;104:14140–5.PubMed ↗Scholar ↗
  236. Wong BX, Tsatsanis A, Lim LQ, Adlard PA, Bush AI, Duce JA. β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS One 2014;9:e114174.PubMed ↗Scholar ↗
  237. Faux NG, Rembach A, Wiley J, et al. An anemia of Alzheimer's disease. Mol Psychiatry 2014;19:1227–34.PubMed ↗Scholar ↗
  238. Ashraf A, So P-W. Spotlight on Ferroptosis, Iron-Dependent Cell Death in Alzheimer's Disease. Front Aging Neurosci 2020;12:196.PubMed ↗Scholar ↗
  239. Rohe M, Hartl D, Fjorback AN, Klose J, Willnow TE. SORLA-mediated trafficking of TrkB enhances the response of neurons to BDNF. PLoS One 2013;8:e72164.PubMed ↗Scholar ↗
  240. Chen Q, Zhou Z, Zhang L, Xu S, Chen C, Yu Z. The cellular distribution and Ser262 phosphorylation of tau protein are regulated by BDNF in vitro. PLoS One 2014;9:e91793.PubMed ↗Scholar ↗
  241. Erickson KI, Prakash RS, Voss MW, et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 2010;30:5368–75.PubMed ↗Scholar ↗
  242. Perovic M, Tesic V, Mladenovic Djordjevic A, et al. BDNF transcripts, proBDNF and proNGF, in the cortex and hippocampus throughout the life span of the rat. Age (Dordr) 2013;35:2057–70.PubMed ↗Scholar ↗
  243. Barthelson K, Newman M, Lardelli M. Sorting Out the Role of the Sortilin-Related Receptor 1 in Alzheimer's Disease. J Alzheimers Dis Rep 2020;4:123–40.PubMed ↗Scholar ↗
  244. Kosugi I, Shinmura Y, Li RY, et al. Murine cytomegalovirus induces apoptosis in non-infected cells of the developing mouse brain and blocks apoptosis in primary neuronal culture. Acta Neuropathol 1998;96:239–47.PubMed ↗Scholar ↗
  245. Levesque-Sergerie J-P, Duquette M, Thibault C, Delbecchi L, Bissonnette N. Detection limits of several commercial reverse transcriptase enzymes, Impact on the low- and high-abundance transcript levels assessed by quantitative RT-PCR. BMC Mol Biol 2007;8:93.PubMed ↗Scholar ↗

Original references (PDF)

The reference list exactly as submitted with the entry.

If the embedded viewer doesn’t load, open the PDF in a new tab or download it. (Inline viewing requires the site to be served together as a folder.)